1. Home
  2. GDTC vs SINT Comparison

GDTC vs SINT Comparison

Compare GDTC & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.94

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$3.73

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDTC
SINT
Founded
2018
1996
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.5M
14.6M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
GDTC
SINT
Price
$0.94
$3.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
38.4K
41.4K
Earning Date
04-24-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$573,193.00
$1,270,000.00
Revenue This Year
$5.37
N/A
Revenue Next Year
N/A
$80.00
P/E Ratio
N/A
N/A
Revenue Growth
63.03
N/A
52 Week Low
$0.89
$1.71
52 Week High
$3.68
$7.36

Technical Indicators

Market Signals
Indicator
GDTC
SINT
Relative Strength Index (RSI) 20.48 50.94
Support Level $0.89 $3.65
Resistance Level $1.39 $3.94
Average True Range (ATR) 0.13 0.23
MACD -0.04 -0.01
Stochastic Oscillator 7.13 35.00

Price Performance

Historical Comparison
GDTC
SINT

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: